Applied Biosystems Group, an Applera Corporation business, together with its joint venture partner MDS Sciex, a division of MDS Inc., today announced the launch of two new mass spectrometers, the 3200 Q TRAP and the API 3200 LC/MS/MS Systems with Turbo V Source for added sensitivity, throughput, and cost-effectiveness in mass spectrometry-based workflows.
These systems are designed for food and beverage, environmental, forensic, clinical research, and pharmaceutical analysis markets.
By incorporating the Applied Biosystems/MDS SCIEX proven Turbo V source and API 4000 LC/MS/MS System-series interface and ionization sources into a smaller platform, these new systems provide increased sensitivity, greater flexibility, and improved ease-of-use when compared to comparably priced instruments. The ceramic interface of the API 3200 and 3200 Q TRAP LC/MS/MS Systems reduces chemical background and improves sensitivity under LC conditions, yielding better efficiency, relative to older source technologies, especially at higher flow rates.
"These new instruments extend the unique capabilities of the API 4000 LC/MS/MS System technology to two mid-level platforms at attractive prices, creating a tremendous value for the customer due to significantly improved sensitivity, throughput, and robustness," said Laura Lauman, Division President of the Proteomics and Small Molecule Business for Applied Biosystems.
The API 3200 LC/MS/MS System with Turbo V source is a triple quadrupole for quantitation and analyte detection studies. The system provides improved performance, especially at high flow rates, allowing for easy method transfer from LC/UV to LC/MS/MS workflows. This method transfer to LC/MS/MS workflows offers the advantages of improved sensitivity, speed, and simplified sample preparation in the pharmaceutical analysis, environmental, and forensic markets. Additionally, because the Turbo V source family is now compatible with five Applied Biosystems/MDS SCIEX LC/MS/MS systems, method development can be carried out on these new instruments with simple transfer to the higher sensitivity systems.
"With three innovative new mass spectrometers released to date this year, Applied Biosystems/MDS SCIEX again demonstrates its commitment to continued leadership in mass spectrometry instrumentation," said Andy Boorn, Ph.D., President of MDS Sciex.
The 3200 Q TRAP System is a hybrid triple quadrupole-linear ion trap for small molecule identification, characterization and quantification and protein biomarker discovery, validation, and quantification. The system provides greater than two-fold sensitivity increase in linear ion trap mode at all flow rates, and up to a 5-fold signal-to-noise increase in traditional triple quadrupole mode over its predecessor, the Q TRAP LC/MS/MS System.
"The 3200 Q TRAP and the API 3200 LC/MS/MS systems add analytical options for customers in the applied markets of environmental, forensic, and food and beverage testing," said Mark Stevenson, Division President of the Applied Markets Business for Applied Biosystems. "Customers in these markets require robust, sensitive systems to identify, for example, contaminants at trace levels."
The 3200 Q TRAP System will be part of the new BIOiTRAQ Systems used for proteomics and biomarker studies and will incorporate the NanoSpray source and nanoflow interface that were originally launched with the 4000 Q TRAP LC/MS/MS system. For nanoflow applications, the heated nanoflow interface provides increased stability, ruggedness, flexibility and ease of use, especially for negative ion and polarity switching analyses when compared to other currently available systems.